SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'RIB'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BX4_A_ADNA350_1
(PROTEIN (ADENOSINE
KINASE))		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.35A 1bx4A-1rk2A:
32.4		 1bx4A-1rk2A:
28.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BX4_A_ADNA350_1
(PROTEIN (ADENOSINE
KINASE))		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.29A 1bx4A-3go7A:
27.3		 1bx4A-3go7A:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KYV_C_RBFC503_1
(6,7-DIMETHYL-8-RIBIT
YLLUMAZINE SYNTHASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ILE A 112
HIS A  17
GLY A  42
GLU A 143
ILE A 251
 None
None
RIB  A 311 (-3.4A)
RIB  A 311 (-2.5A)
None
 1.24A 1kyvB-1rk2A:
4.1
1kyvC-1rk2A:
undetectable		 1kyvB-1rk2A:
19.74
1kyvC-1rk2A:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LII_A_ADNA699_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.30A 1liiA-1rk2A:
33.4		 1liiA-1rk2A:
26.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LII_A_ADNA699_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.34A 1liiA-3go7A:
29.6		 1liiA-3go7A:
26.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIK_A_ADNA699_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.42A 1likA-1rk2A:
32.9		 1likA-1rk2A:
26.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIK_A_ADNA699_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.46A 1likA-3go7A:
29.5		 1likA-3go7A:
26.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK2_A_ACAA91_1
(TISSUE-TYPE
PLASMINOGEN
ACTIVATOR)		 2c40 INOSINE-URIDINE
PREFERRING
NUCLEOSIDE HYDROLASE
FAMILY PROTEIN
(Bacillus
anthracis) 		4 / 8 VAL A 231
ASP A  13
ASP A 247
HIS A  80
 None
None
RIB  A1312 ( 2.5A)
None
 1.15A 1pk2A-2c40A:
undetectable		 1pk2A-2c40A:
15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XZX_X_T3X500_2
(THYROID HORMONE
RECEPTOR BETA-1)		 2c40 INOSINE-URIDINE
PREFERRING
NUCLEOSIDE HYDROLASE
FAMILY PROTEIN
(Bacillus
anthracis) 		3 / 3 PHE A 175
ARG A 156
ASN A 160
 None
None
RIB  A1312 (-3.3A)
 0.91A 1xzxX-2c40A:
undetectable		 1xzxX-2c40A:
23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXG_A_IBPA2002_1
(SERUM ALBUMIN)		 3rcy MANDELATE
RACEMASE/MUCONATE
LACTONIZING
ENZYME-LIKE PROTEIN
(Roseovarius
sp.
TM1035) 		4 / 8 ALA A 257
ALA A 308
GLU A 335
LEU A 262
 None
None
None
RIB  A 433 (-4.7A)
 0.69A 2bxgA-3rcyA:
undetectable		 2bxgA-3rcyA:
19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C49_A_ADNA1301_1
(SUGAR KINASE MJ0406)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ALA A  98
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.6A)
RIB  A 311 (-3.1A)
 0.33A 2c49A-1rk2A:
37.0		 2c49A-1rk2A:
24.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C49_A_ADNA1301_1
(SUGAR KINASE MJ0406)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ALA A 106
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-3.3A)
RIB  A 305 (-2.9A)
 0.31A 2c49A-3go7A:
34.4		 2c49A-3go7A:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C49_B_ADNB1301_1
(SUGAR KINASE MJ0406)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 7 ASP A  16
GLY A  41
GLY A  42
ASN A  46
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
 0.41A 2c49B-1rk2A:
34.5		 2c49B-1rk2A:
24.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C49_B_ADNB1301_1
(SUGAR KINASE MJ0406)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		4 / 7 ASP A  25
GLY A  50
GLY A  51
ASN A  55
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
 0.51A 2c49B-3go7A:
31.2		 2c49B-3go7A:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DRD_A_MIYA2001_1
(ACRB)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 9 GLY A  44
ASN A  14
ILE A  13
ALA A  62
VAL A  87
 None
RIB  A 311 (-4.1A)
None
None
None
 1.22A 2drdA-1rk2A:
undetectable		 2drdA-1rk2A:
15.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HZQ_A_STRA300_1
(APOLIPOPROTEIN D)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		4 / 7 THR A  27
ALA A  54
ASN A  55
LEU A  82
 None
None
RIB  A 305 (-3.2A)
None
 1.03A 2hzqA-3go7A:
undetectable		 2hzqA-3go7A:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
ASN A  46
ALA A 168
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 1.04A 2pkkA-1rk2A:
34.8		 2pkkA-1rk2A:
25.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 SER A  12
ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 None
RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.51A 2pkkA-1rk2A:
34.8		 2pkkA-1rk2A:
25.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKK_A_2FAA501_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		7 / 12 SER A  21
ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 ( 4.7A)
RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.55A 2pkkA-3go7A:
31.0		 2pkkA-3go7A:
26.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKM_A_ADNA501_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 SER A  12
ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 None
RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.52A 2pkmA-1rk2A:
34.6		 2pkmA-1rk2A:
25.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKM_A_ADNA501_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		7 / 12 SER A  21
ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 ( 4.7A)
RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.55A 2pkmA-3go7A:
30.9		 2pkmA-3go7A:
26.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKM_A_ADNA501_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 SER A 103
ALA A 124
GLY A 104
ASN A  23
ALA A  78
GLY A  50
 None
None
None
RIB  A 305 (-3.7A)
None
RIB  A 305 ( 3.7A)
 1.48A 2pkmA-3go7A:
30.9		 2pkmA-3go7A:
26.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PKM_A_ADNA501_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 SER A 103
ALA A 124
GLY A 104
ASN A  23
ALA A  78
GLY A  51
 None
None
None
RIB  A 305 (-3.7A)
None
RIB  A 305 (-3.1A)
 1.38A 2pkmA-3go7A:
30.9		 2pkmA-3go7A:
26.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AOD_A_MIYA2001_1
(ACRIFLAVINE
RESISTANCE PROTEIN B)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 8 SER A  12
PHE A 257
GLY A 259
ASN A  46
ALA A 282
 None
ADP  A 310 ( 4.4A)
None
RIB  A 311 (-3.3A)
ADP  A 310 (-3.3A)
 1.46A 3aodA-1rk2A:
undetectable		 3aodA-1rk2A:
15.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3F8W_C_ADNC302_1
(PURINE-NUCLEOSIDE
PHOSPHORYLASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ALA A 286
GLY A 283
VAL A 282
GLY A 239
VAL A  58
 None
None
None
RIB  A 305 ( 4.5A)
None
 1.20A 3f8wC-3go7A:
undetectable		 3f8wC-3go7A:
23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MJR_D_AC2D601_1
(DEOXYCYTIDINE KINASE)		 4rk1 RIBOSE
TRANSCRIPTIONAL
REGULATOR
(Enterococcus
faecium) 		4 / 8 PHE A  80
GLN A 296
ARG A 165
ASP A 168
 RIB  A 401 (-3.6A)
RIB  A 401 (-3.4A)
None
None
 1.18A 3mjrD-4rk1A:
undetectable		 3mjrD-4rk1A:
24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TBG_C_RTZC1_1
(CYTOCHROME P450 2D6)		 4rk1 RIBOSE
TRANSCRIPTIONAL
REGULATOR
(Enterococcus
faecium) 		5 / 12 LEU A 250
PHE A 227
PHE A  80
GLY A 171
ASP A 279
 None
RIB  A 401 (-4.6A)
RIB  A 401 (-3.6A)
None
RIB  A 401 (-2.7A)
 1.29A 3tbgC-4rk1A:
undetectable		 3tbgC-4rk1A:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UBO_A_ADNA353_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.30A 3uboA-1rk2A:
34.8		 3uboA-1rk2A:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UBO_A_ADNA353_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.85A 3uboA-1rk2A:
34.8		 3uboA-1rk2A:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UBO_A_ADNA353_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.42A 3uboA-3go7A:
30.6		 3uboA-3go7A:
28.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UBO_A_ADNA353_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 GLY A  50
GLY A  51
ASN A  55
GLU A 146
GLY A 239
 RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.6A)
RIB  A 305 ( 4.5A)
 0.83A 3uboA-3go7A:
30.6		 3uboA-3go7A:
28.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UBO_B_ADNB353_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.31A 3uboB-1rk2A:
35.8		 3uboB-1rk2A:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UBO_B_ADNB353_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.82A 3uboB-1rk2A:
35.8		 3uboB-1rk2A:
28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UBO_B_ADNB353_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.34A 3uboB-3go7A:
31.7		 3uboB-3go7A:
28.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UQ6_A_ADNA401_1
(ADENOSINE KINASE,
PUTATIVE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.35A 3uq6A-1rk2A:
33.4		 3uq6A-1rk2A:
25.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UQ6_A_ADNA401_1
(ADENOSINE KINASE,
PUTATIVE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.38A 3uq6A-3go7A:
27.7		 3uq6A-3go7A:
24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UQ6_B_ADNB401_1
(ADENOSINE KINASE,
PUTATIVE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.36A 3uq6B-3go7A:
26.8		 3uq6B-3go7A:
24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAQ_A_ADNA401_1
(PUTATIVE ADENOSINE
KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.42A 3vaqA-1rk2A:
33.0		 3vaqA-1rk2A:
25.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAQ_A_ADNA401_1
(PUTATIVE ADENOSINE
KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.44A 3vaqA-3go7A:
27.3		 3vaqA-3go7A:
24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAQ_B_ADNB401_1
(PUTATIVE ADENOSINE
KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.42A 3vaqB-3go7A:
26.5		 3vaqB-3go7A:
24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAQ_B_ADNB401_1
(PUTATIVE ADENOSINE
KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 GLY A  51
ASN A  55
VAL A 120
GLY A 239
ASP A 242
 RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 1.03A 3vaqB-3go7A:
26.5		 3vaqB-3go7A:
24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAS_A_ADNA401_1
(PUTATIVE ADENOSINE
KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.34A 3vasA-1rk2A:
33.0		 3vasA-1rk2A:
25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAS_A_ADNA401_1
(PUTATIVE ADENOSINE
KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.39A 3vasA-3go7A:
27.5		 3vasA-3go7A:
24.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAS_B_ADNB401_1
(PUTATIVE ADENOSINE
KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASN A  46
ILE A  82
GLY A 259
VAL A   9
GLY A  55
 RIB  A 311 (-3.3A)
None
None
None
None
 0.91A 3vasB-1rk2A:
23.4		 3vasB-1rk2A:
25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAS_B_ADNB401_1
(PUTATIVE ADENOSINE
KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.31A 3vasB-1rk2A:
23.4		 3vasB-1rk2A:
25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAS_B_ADNB401_1
(PUTATIVE ADENOSINE
KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.33A 3vasB-3go7A:
18.7		 3vasB-3go7A:
24.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAS_B_ADNB401_1
(PUTATIVE ADENOSINE
KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 GLY A  51
ASN A  55
VAL A 120
GLY A 239
ASP A 242
 RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.99A 3vasB-3go7A:
18.7		 3vasB-3go7A:
24.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VYW_A_SAMA501_1
(MNMC2)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		4 / 6 GLU A 196
ASP A 242
ASN A 116
GLU A 115
 None
RIB  A 305 (-2.9A)
None
None
 1.20A 3vywA-3go7A:
2.7		 3vywA-3go7A:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VYW_D_SAMD401_1
(MNMC2)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		4 / 5 GLU A 196
ASP A 242
ASN A 116
GLU A 115
 None
RIB  A 305 (-2.9A)
None
None
 1.16A 3vywD-3go7A:
undetectable		 3vywD-3go7A:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZTV_A_ADNA1600_1
(NAD NUCLEOTIDASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 9 ASN A  46
GLY A  42
GLY A  41
GLY A  44
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 1.03A 3ztvA-1rk2A:
undetectable		 3ztvA-1rk2A:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZTV_A_ADNA1600_1
(NAD NUCLEOTIDASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 9 ASN A  55
GLY A  51
GLY A  50
GLY A  53
ASP A 242
 RIB  A 305 (-3.2A)
RIB  A 305 (-3.1A)
RIB  A 305 ( 3.7A)
None
RIB  A 305 (-2.9A)
 1.04A 3ztvA-3go7A:
undetectable		 3ztvA-3go7A:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_A_ADNA401_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.50A 4dc3A-3go7A:
26.1		 4dc3A-3go7A:
24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.39A 4dc3B-1rk2A:
33.0		 4dc3B-1rk2A:
25.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DC3_B_2FAB401_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.43A 4dc3B-3go7A:
27.4		 4dc3B-3go7A:
24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3A_A_ADNA500_1
(SUGAR KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.29A 4e3aA-1rk2A:
35.5		 4e3aA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3A_A_ADNA500_1
(SUGAR KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4e3aA-1rk2A:
35.5		 4e3aA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3A_A_ADNA500_1
(SUGAR KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.32A 4e3aA-3go7A:
31.6		 4e3aA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3A_B_ADNB500_1
(SUGAR KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.28A 4e3aB-1rk2A:
35.3		 4e3aB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3A_B_ADNB500_1
(SUGAR KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4e3aB-1rk2A:
35.3		 4e3aB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3A_B_ADNB500_1
(SUGAR KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.39A 4e3aB-3go7A:
31.3		 4e3aB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3A_B_ADNB500_1
(SUGAR KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 GLY A  50
GLY A  51
ASN A  55
GLU A 146
GLY A 239
 RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.6A)
RIB  A 305 ( 4.5A)
 0.74A 4e3aB-3go7A:
31.3		 4e3aB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKS_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.35A 4jksA-1rk2A:
35.6		 4jksA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKS_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4jksA-1rk2A:
35.6		 4jksA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKS_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.78A 4jksA-1rk2A:
35.6		 4jksA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKS_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.47A 4jksA-3go7A:
31.8		 4jksA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKS_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4jksB-1rk2A:
35.6		 4jksB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKS_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4jksB-1rk2A:
35.6		 4jksB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKS_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.78A 4jksB-1rk2A:
35.6		 4jksB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKS_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.47A 4jksB-3go7A:
31.8		 4jksB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_A_ADNA500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A  18
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
 0.98A 4jkuA-1rk2A:
35.6		 4jkuA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_A_ADNA500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4jkuA-1rk2A:
35.6		 4jkuA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_A_ADNA500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4jkuA-1rk2A:
35.6		 4jkuA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_A_ADNA500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A  18
GLU A 143
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-2.5A)
 0.85A 4jkuA-1rk2A:
35.6		 4jkuA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_A_ADNA500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.77A 4jkuA-1rk2A:
35.6		 4jkuA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_A_ADNA500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.46A 4jkuA-3go7A:
31.8		 4jkuA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_B_ADNB500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.25A 4jkuB-1rk2A:
35.6		 4jkuB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_B_ADNB500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.82A 4jkuB-1rk2A:
35.6		 4jkuB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JKU_B_ADNB500_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.32A 4jkuB-3go7A:
31.8		 4jkuB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K0B_B_SAMB504_0
(S-ADENOSYLMETHIONINE
SYNTHASE)		 4rk0 LACI FAMILY
SUGAR-BINDING
TRANSCRIPTIONAL
REGULATOR
(Enterococcus
faecalis) 		4 / 8 ASN A  81
LEU A 224
ASN A 248
ILE A 247
 RIB  A 401 (-3.3A)
None
RIB  A 401 (-3.8A)
None
 0.89A 4k0bA-4rk0A:
undetectable		 4k0bA-4rk0A:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A  18
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
 0.99A 4k8cA-1rk2A:
35.6		 4k8cA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.32A 4k8cA-1rk2A:
35.6		 4k8cA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4k8cA-1rk2A:
35.6		 4k8cA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A  18
GLU A 143
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-2.5A)
 0.83A 4k8cA-1rk2A:
35.6		 4k8cA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.79A 4k8cA-1rk2A:
35.6		 4k8cA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_A_ADNA401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.50A 4k8cA-3go7A:
31.7		 4k8cA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.32A 4k8cB-1rk2A:
35.5		 4k8cB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4k8cB-1rk2A:
35.5		 4k8cB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.77A 4k8cB-1rk2A:
35.5		 4k8cB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8C_B_ADNB401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.49A 4k8cB-3go7A:
31.6		 4k8cB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8K_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.36A 4k8kA-1rk2A:
35.5		 4k8kA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8K_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4k8kA-1rk2A:
35.5		 4k8kA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8K_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.78A 4k8kA-1rk2A:
35.5		 4k8kA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8K_A_ADNA401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.47A 4k8kA-3go7A:
31.7		 4k8kA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8K_B_ADNB403_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.35A 4k8kB-1rk2A:
35.6		 4k8kB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8K_B_ADNB403_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.82A 4k8kB-1rk2A:
35.6		 4k8kB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8K_B_ADNB403_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.77A 4k8kB-1rk2A:
35.6		 4k8kB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8K_B_ADNB403_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.46A 4k8kB-3go7A:
31.7		 4k8kB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8P_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.27A 4k8pA-1rk2A:
35.6		 4k8pA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8P_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.79A 4k8pA-1rk2A:
35.6		 4k8pA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8P_A_ADNA401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.31A 4k8pA-3go7A:
31.7		 4k8pA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8P_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.27A 4k8pB-1rk2A:
35.5		 4k8pB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8P_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.79A 4k8pB-1rk2A:
35.5		 4k8pB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8P_B_ADNB401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.31A 4k8pB-3go7A:
31.7		 4k8pB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8T_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.30A 4k8tA-1rk2A:
35.5		 4k8tA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8T_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4k8tA-1rk2A:
35.5		 4k8tA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8T_A_ADNA401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.31A 4k8tA-3go7A:
31.6		 4k8tA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8T_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.31A 4k8tB-1rk2A:
35.5		 4k8tB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8T_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4k8tB-1rk2A:
35.5		 4k8tB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K8T_B_ADNB401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.34A 4k8tB-3go7A:
31.7		 4k8tB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K93_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.27A 4k93A-1rk2A:
35.7		 4k93A-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K93_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4k93A-1rk2A:
35.7		 4k93A-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K93_A_ADNA401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.32A 4k93A-3go7A:
31.8		 4k93A-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K93_B_ADNB402_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.27A 4k93B-1rk2A:
35.7		 4k93B-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K93_B_ADNB402_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4k93B-1rk2A:
35.7		 4k93B-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K93_B_ADNB402_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.31A 4k93B-3go7A:
31.8		 4k93B-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9C_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.27A 4k9cA-1rk2A:
35.7		 4k9cA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9C_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4k9cA-1rk2A:
35.7		 4k9cA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9C_A_ADNA401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.32A 4k9cA-3go7A:
31.8		 4k9cA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9C_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.27A 4k9cB-1rk2A:
35.6		 4k9cB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9C_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4k9cB-1rk2A:
35.6		 4k9cB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9C_B_ADNB401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.31A 4k9cB-3go7A:
31.8		 4k9cB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9I_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.29A 4k9iA-1rk2A:
35.5		 4k9iA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9I_A_ADNA401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4k9iA-1rk2A:
35.5		 4k9iA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9I_A_ADNA401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.33A 4k9iA-3go7A:
31.8		 4k9iA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9I_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.29A 4k9iB-1rk2A:
35.6		 4k9iB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9I_B_ADNB401_1
(SUGAR KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.79A 4k9iB-1rk2A:
35.6		 4k9iB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K9I_B_ADNB401_1
(SUGAR KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.33A 4k9iB-3go7A:
31.8		 4k9iB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAD_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.28A 4kadA-1rk2A:
35.6		 4kadA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAD_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4kadA-1rk2A:
35.6		 4kadA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAD_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.31A 4kadA-3go7A:
31.8		 4kadA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAD_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.27A 4kadB-1rk2A:
32.4		 4kadB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAD_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4kadB-1rk2A:
32.4		 4kadB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAD_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.33A 4kadB-3go7A:
31.7		 4kadB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAH_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4kahA-1rk2A:
35.7		 4kahA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAH_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4kahA-1rk2A:
35.7		 4kahA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAH_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.79A 4kahA-1rk2A:
35.7		 4kahA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAH_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.47A 4kahA-3go7A:
31.8		 4kahA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAH_B_ADNB502_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4kahB-1rk2A:
35.7		 4kahB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAH_B_ADNB502_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.79A 4kahB-1rk2A:
35.7		 4kahB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAH_B_ADNB502_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.79A 4kahB-1rk2A:
35.7		 4kahB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAH_B_ADNB502_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.49A 4kahB-3go7A:
31.7		 4kahB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A  18
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
 0.97A 4kalA-1rk2A:
35.6		 4kalA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4kalA-1rk2A:
35.6		 4kalA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4kalA-1rk2A:
35.6		 4kalA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A  18
GLU A 143
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-2.5A)
 0.83A 4kalA-1rk2A:
35.6		 4kalA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.79A 4kalA-1rk2A:
35.6		 4kalA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.45A 4kalA-3go7A:
31.8		 4kalA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A  18
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
 0.97A 4kalB-1rk2A:
35.6		 4kalB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.36A 4kalB-1rk2A:
35.6		 4kalB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4kalB-1rk2A:
35.6		 4kalB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A  18
GLU A 143
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-2.5A)
 0.84A 4kalB-1rk2A:
35.6		 4kalB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.79A 4kalB-1rk2A:
35.6		 4kalB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAL_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.47A 4kalB-3go7A:
31.8		 4kalB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4kanA-1rk2A:
35.7		 4kanA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4kanA-1rk2A:
35.7		 4kanA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.78A 4kanA-1rk2A:
35.7		 4kanA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.47A 4kanA-3go7A:
31.8		 4kanA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4kanB-1rk2A:
35.7		 4kanB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4kanB-1rk2A:
35.7		 4kanB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.79A 4kanB-1rk2A:
35.7		 4kanB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.48A 4kanB-3go7A:
31.7		 4kanB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KBE_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.35A 4kbeA-1rk2A:
35.6		 4kbeA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KBE_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4kbeA-1rk2A:
35.6		 4kbeA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KBE_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.79A 4kbeA-1rk2A:
35.6		 4kbeA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KBE_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.48A 4kbeA-3go7A:
31.8		 4kbeA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KBE_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.33A 4kbeB-1rk2A:
35.6		 4kbeB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KBE_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4kbeB-1rk2A:
35.6		 4kbeB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KBE_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.80A 4kbeB-1rk2A:
35.6		 4kbeB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KBE_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.48A 4kbeB-3go7A:
27.4		 4kbeB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L7I_B_SAMB501_0
(S-ADENOSYLMETHIONINE
SYNTHASE)		 4rk0 LACI FAMILY
SUGAR-BINDING
TRANSCRIPTIONAL
REGULATOR
(Enterococcus
faecalis) 		4 / 8 ASN A  81
LEU A 224
ASN A 248
ILE A 247
 RIB  A 401 (-3.3A)
None
RIB  A 401 (-3.8A)
None
 0.94A 4l7iA-4rk0A:
undetectable		 4l7iA-4rk0A:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.35A 4lbgA-1rk2A:
35.5		 4lbgA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4lbgA-1rk2A:
35.5		 4lbgA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.77A 4lbgA-1rk2A:
35.5		 4lbgA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.47A 4lbgA-3go7A:
31.6		 4lbgA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.33A 4lbgB-1rk2A:
35.6		 4lbgB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4lbgB-1rk2A:
35.6		 4lbgB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.78A 4lbgB-1rk2A:
35.6		 4lbgB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.48A 4lbgB-3go7A:
31.7		 4lbgB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBX_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.31A 4lbxA-1rk2A:
35.7		 4lbxA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBX_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4lbxA-1rk2A:
35.7		 4lbxA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBX_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.34A 4lbxA-3go7A:
31.7		 4lbxA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBX_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.29A 4lbxB-1rk2A:
35.6		 4lbxB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBX_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4lbxB-1rk2A:
35.6		 4lbxB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBX_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.34A 4lbxB-3go7A:
31.8		 4lbxB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LC4_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.28A 4lc4A-1rk2A:
35.6		 4lc4A-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LC4_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4lc4A-1rk2A:
35.6		 4lc4A-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LC4_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.33A 4lc4A-3go7A:
31.6		 4lc4A-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LC4_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.29A 4lc4B-1rk2A:
35.4		 4lc4B-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LC4_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.82A 4lc4B-1rk2A:
35.4		 4lc4B-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LC4_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.33A 4lc4B-3go7A:
31.6		 4lc4B-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LCA_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4lcaA-1rk2A:
35.7		 4lcaA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LCA_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.80A 4lcaA-1rk2A:
35.7		 4lcaA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LCA_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.80A 4lcaA-1rk2A:
35.7		 4lcaA-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LCA_A_ADNA401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.49A 4lcaA-3go7A:
31.8		 4lcaA-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LCA_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ILE A 100
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 0.34A 4lcaB-1rk2A:
35.5		 4lcaB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LCA_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
GLU A 143
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.5A)
RIB  A 311 (-3.1A)
 0.81A 4lcaB-1rk2A:
35.5		 4lcaB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LCA_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 GLY A  41
GLY A  42
ASN A  46
ILE A 110
ASP A 255
 RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 ( 4.6A)
RIB  A 311 (-3.1A)
 0.78A 4lcaB-1rk2A:
35.5		 4lcaB-1rk2A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LCA_B_ADNB401_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
ILE A 108
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
None
RIB  A 305 (-2.9A)
 0.48A 4lcaB-3go7A:
31.7		 4lcaB-3go7A:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_A_ADNA401_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 ASP A  25
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.45A 4n09A-3go7A:
28.9		 4n09A-3go7A:
27.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_B_ADNB401_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.33A 4n09B-1rk2A:
33.4		 4n09B-1rk2A:
26.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_B_ADNB401_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.52A 4n09B-3go7A:
28.7		 4n09B-3go7A:
27.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_C_ADNC401_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.35A 4n09C-1rk2A:
33.6		 4n09C-1rk2A:
26.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_C_ADNC401_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.51A 4n09C-3go7A:
28.9		 4n09C-3go7A:
27.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_D_ADND401_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.35A 4n09D-1rk2A:
33.3		 4n09D-1rk2A:
26.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_D_ADND401_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.54A 4n09D-3go7A:
28.7		 4n09D-3go7A:
27.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O2B_D_LOCD503_1
(TUBULIN ALPHA-1B
CHAIN
TUBULIN BETA-2B
CHAIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		3 / 3 SER A  21
ALA A  72
VAL A  97
 RIB  A 305 ( 4.7A)
None
None
 0.60A 4o2bC-3go7A:
4.2		 4o2bC-3go7A:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
ASN A  46
ALA A 168
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.3A)
None
RIB  A 311 (-3.1A)
 1.05A 4ubeA-1rk2A:
34.7		 4ubeA-1rk2A:
25.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		6 / 12 SER A  12
ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 None
RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.52A 4ubeA-1rk2A:
34.7		 4ubeA-1rk2A:
25.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBE_A_2FAA401_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 SER A  21
ASP A  25
GLY A  50
GLY A  51
ASN A  55
ASP A 242
 RIB  A 305 ( 4.7A)
RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.9A)
 0.52A 4ubeA-3go7A:
31.0		 4ubeA-3go7A:
26.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XJE_A_TOYA202_1
(AADB)		 2c40 INOSINE-URIDINE
PREFERRING
NUCLEOSIDE HYDROLASE
FAMILY PROTEIN
(Bacillus
anthracis) 		4 / 8 ASP A  14
ASP A 247
TYR A 243
ASP A  13
 CA  A1311 ( 2.3A)
RIB  A1312 ( 2.5A)
None
None
 0.81A 4xjeA-2c40A:
undetectable		 4xjeA-2c40A:
21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XT8_A_TMQA302_1
(RV2671)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ILE A  13
SER A  12
GLY A  44
ALA A  45
GLU A 143
 None
None
None
None
RIB  A 311 (-2.5A)
 1.20A 4xt8A-1rk2A:
undetectable		 4xt8A-1rk2A:
26.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BW4_A_SAMA301_0
(16S RRNA
(ADENINE(1408)-N(1))
-METHYLTRANSFERASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 12 GLY A 241
GLY A 239
THR A 277
ASP A 242
ILE A 191
 None
RIB  A 305 ( 4.5A)
None
RIB  A 305 (-2.9A)
None
 0.82A 5bw4A-3go7A:
undetectable		 5bw4A-3go7A:
28.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KB5_A_ADNA401_1
(ADENOSINE KINASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		5 / 12 ASP A  16
GLY A  41
GLY A  42
ASN A  46
ASP A 255
 RIB  A 311 (-2.8A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.4A)
RIB  A 311 (-3.3A)
RIB  A 311 (-3.1A)
 0.33A 5kb5A-1rk2A:
33.9		 5kb5A-1rk2A:
28.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KB5_A_ADNA401_1
(ADENOSINE KINASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		6 / 12 ASP A  25
GLY A  50
GLY A  51
ASN A  55
GLY A 239
ASP A 242
 RIB  A 305 (-2.8A)
RIB  A 305 ( 3.7A)
RIB  A 305 (-3.1A)
RIB  A 305 (-3.2A)
RIB  A 305 ( 4.5A)
RIB  A 305 (-2.9A)
 0.33A 5kb5A-3go7A:
29.8		 5kb5A-3go7A:
26.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L6E_B_ACTB401_0
(N6-ADENOSINE-METHYLT
RANSFERASE 70 KDA
SUBUNIT
N6-ADENOSINE-METHYLT
RANSFERASE SUBUNIT
METTL14)		 3rcy MANDELATE
RACEMASE/MUCONATE
LACTONIZING
ENZYME-LIKE PROTEIN
(Roseovarius
sp.
TM1035) 		4 / 6 GLU A 260
ARG A 261
LEU A 262
ARG A 286
 MG  A 500 (-2.6A)
None
RIB  A 433 (-4.7A)
None
 1.15A 5l6eA-3rcyA:
undetectable
5l6eB-3rcyA:
undetectable		 5l6eA-3rcyA:
20.24
5l6eB-3rcyA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5O96_G_SAMG501_0
(RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE E)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 11 GLY A  53
GLU A 146
GLY A  20
VAL A 168
ALA A 245
 None
RIB  A 305 (-2.6A)
None
None
None
 0.86A 5o96G-3go7A:
3.3		 5o96G-3go7A:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_A_C2FA3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 5 ASN A 166
ASP A 255
ASN A  46
ASP A  16
 None
RIB  A 311 (-3.1A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.8A)
 1.15A 5vooA-1rk2A:
3.1		 5vooA-1rk2A:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_A_C2FA3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 5 ASP A 255
ASN A  46
ASP A  16
ASN A 108
 RIB  A 311 (-3.1A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.8A)
None
 1.23A 5vooA-1rk2A:
3.1		 5vooA-1rk2A:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_A_C2FA3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		4 / 5 ASN A 169
ASP A 242
ASN A  55
ASP A  25
 None
RIB  A 305 (-2.9A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.8A)
 1.05A 5vooA-3go7A:
2.2		 5vooA-3go7A:
24.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_B_C2FB702_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 5 ASP A 255
ASN A  46
ASP A  16
ASN A 108
 RIB  A 311 (-3.1A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.8A)
None
 1.23A 5vooB-1rk2A:
3.1		 5vooB-1rk2A:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_C_C2FC702_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 5 ASN A 166
ASP A 255
ASN A  46
ASP A  16
 None
RIB  A 311 (-3.1A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.8A)
 1.16A 5vooC-1rk2A:
3.0		 5vooC-1rk2A:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_C_C2FC702_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 5 ASP A 255
ASN A  46
ASP A  16
ASN A 108
 RIB  A 311 (-3.1A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.8A)
None
 1.25A 5vooC-1rk2A:
3.0		 5vooC-1rk2A:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_C_C2FC702_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		4 / 5 ASN A 169
ASP A 242
ASN A  55
ASP A  25
 None
RIB  A 305 (-2.9A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.8A)
 1.06A 5vooC-3go7A:
undetectable		 5vooC-3go7A:
24.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_D_C2FD3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 5 ASP A 255
ASN A  46
ASP A  16
ASN A 108
 RIB  A 311 (-3.1A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.8A)
None
 1.25A 5vooD-1rk2A:
2.2		 5vooD-1rk2A:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_E_C2FE3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 5 ASP A 255
ASN A  46
ASP A  16
ASN A 108
 RIB  A 311 (-3.1A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.8A)
None
 1.24A 5vooE-1rk2A:
2.8		 5vooE-1rk2A:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_E_C2FE3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		4 / 5 ASN A 169
ASP A 242
ASN A  55
ASP A  25
 None
RIB  A 305 (-2.9A)
RIB  A 305 (-3.2A)
RIB  A 305 (-2.8A)
 1.08A 5vooE-3go7A:
2.2		 5vooE-3go7A:
24.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOO_F_C2FF3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)		 1rk2 RIBOKINASE
(Escherichia
coli) 		4 / 4 ASP A 255
ASN A  46
ASP A  16
ASN A 108
 RIB  A 311 (-3.1A)
RIB  A 311 (-3.3A)
RIB  A 311 (-2.8A)
None
 1.22A 5vooF-1rk2A:
2.6		 5vooF-1rk2A:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W97_B_CHDB303_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2
CYTOCHROME C OXIDASE
SUBUNIT 6A2,
MITOCHONDRIAL)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		5 / 11 GLY A  50
THR A  46
THR A  27
ARG A  62
GLY A 239
 RIB  A 305 ( 3.7A)
None
None
None
RIB  A 305 ( 4.5A)
 1.25A 5w97A-3go7A:
undetectable
5w97B-3go7A:
undetectable
5w97g-3go7A:
undetectable		 5w97A-3go7A:
19.54
5w97B-3go7A:
18.75
5w97g-3go7A:
14.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIW_D_LOCD503_1
(TUBULIN ALPHA-1B
CHAIN
TUBULIN BETA CHAIN)		 3go7 RIBOKINASE RBSK
(Mycobacterium
tuberculosis) 		3 / 3 SER A  21
ALA A  72
VAL A  97
 RIB  A 305 ( 4.7A)
None
None
 0.53A 5xiwC-3go7A:
4.8		 5xiwC-3go7A:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YK2_A_ERYA501_0
(PROBABLE CONSERVED
ATP-BINDING PROTEIN
ABC TRANSPORTER)		 2c40 INOSINE-URIDINE
PREFERRING
NUCLEOSIDE HYDROLASE
FAMILY PROTEIN
(Bacillus
anthracis) 		5 / 11 GLU A 171
GLY A  69
ASP A 177
ALA A  37
ILE A  35
 RIB  A1312 (-3.8A)
None
None
None
None
 1.18A 5yk2A-2c40A:
undetectable		 5yk2A-2c40A:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DGX_A_017A101_2
(PROTEASE)		 2c40 INOSINE-URIDINE
PREFERRING
NUCLEOSIDE HYDROLASE
FAMILY PROTEIN
(Bacillus
anthracis) 		3 / 3 GLY A 126
ASP A 247
ILE A 194
 CA  A1311 ( 4.2A)
RIB  A1312 ( 2.5A)
None
 0.59A 6dgxB-2c40A:
undetectable		 6dgxB-2c40A:
12.10